Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
snk01 (2 trials)
Alzheimer Disease (Phase 1)
Cognitive Dysfunction (Phase 1)
Neurodegenerative Diseases (Phase 1)
Psoriasis (Phase 1)
Trials (2 total)
Trial APIs (1 total)